Total Hip Arthroplasty Patients With Systemic Sclerosis Have Worse Medical Outcomes But Clinically Similar Implant Survival Independent of Immunomodulatory Therapy
Patients with SSc undergoing THA experience increased 90-day medical AEs, independent of IMT utilization. Encouragingly, SSc patients demonstrated similar 90-day implant-related AEs and 5-year revision-free survival, suggesting that the major barrier to superior outcomes may not be implant related but rather driven by medical complications.
Authors
- Lee E. Rubin (ORCID: https://orcid.org/0000-0002-7259-6355)
- Michael J. Gouzoulis (ORCID: https://orcid.org/0000-0002-9318-3314)
- Rajiv S. Vasudevan (ORCID: https://orcid.org/0000-0003-0935-0456)
- Helia Hosseini (ORCID: https://orcid.org/0000-0001-5553-1069)
- Jonathan Newman Grauer (ORCID: https://orcid.org/0000-0002-2626-7278)
- Anthony E Seddio (ORCID: https://orcid.org/0000-0003-2425-4251)
Institutions
- Fidal (FR)
- Yale New Haven Hospital (US)
- Yale University (US)
- Konrad-Adenauer-Stiftung (DE)
Publication Details
- Journal
- JAAOS Global Research and Reviews
- Published
- 2025-04-01
- DOI
- https://doi.org/10.5435/jaaosglobal-d-24-00257
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00